← Back to the Areas of Interest
AstraZeneca – Re-evaluating the role of gBRCA in breast cancer
Medscape – A Stepwise Approach To Managing HR+/HER2- Early Breast Cancer: From Risk Assessment To Risk Management
Daiichi Sankyo – Advances in Antibody Drug Conjugates in Solid Tumors: Current Treatments and Emerging Therapies
View the full invitation
Programme and Faculty are preliminary and subject to change.
© 2019 cSLIDE CTI MEETING TECHNOLOGY. All rights reserved.